Abl1tm1Gcos/Abl1+
Myf5tm2Tajb/Myf5tm2Tajb
Myf6tm1Tajb/Myf6tm1Tajb
Myod1tm2.1(icre)Glh/Myod1+
involves: 129S * 129X1/SvJ * C57BL/6J
|
abnormal myogenesis |
J:168843
|
|
decreased physiological sensitivity to xenobiotic |
J:168843
|
Atp11atm1c(KOMP)Wtsi/Atp11atm1c(KOMP)Wtsi
Myf5tm3(cre)Sor/Myf5+
involves: 129S4/SvJaeSor * C57BL/6JJcl * C57BL/6N
|
abnormal myoblast differentiation |
J:262981
|
|
abnormal skeletal muscle regeneration |
J:262981
|
|
normal
muscle phenotype |
J:262981
|
Bcl9tm1.1Agt/Bcl9tm1.1Agt
Bcl9ltm1.1Agt/Bcl9ltm1.1Agt
Myf5tm1(cre)Mrc/Myf5+
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ
|
abnormal muscle development |
J:154476
|
|
decreased skeletal muscle fiber size |
J:154476
|
|
impaired skeletal muscle regeneration |
J:154476
|
Col1a1tm3(tetO-Mirlet7g/Mir21)Gqda/Col1a1+
Myf5tm1(cre)Mrc/Myf5+
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
|
decreased body length |
J:199720
|
|
decreased body size |
J:199720
|
Crppaem2Mbp/Crppaem2Mbp
Myf5tm3(cre)Sor/Myf5+
B6.Cg-Myf5tm3(cre)Sor Crppaem2Mbp
|
abnormal skeletal muscle morphology |
J:324289
|
|
centrally nucleated skeletal muscle fibers |
J:324289
|
|
decreased body weight |
J:324289
|
|
decreased grip strength |
J:324289
|
|
decreased skeletal muscle weight |
J:324289
|
|
dystrophic muscle |
J:324289
|
|
increased circulating creatine kinase level |
J:324289
|
|
increased variability of skeletal muscle fiber size |
J:324289
|
|
premature death |
J:324289
|
|
skeletal muscle fiber necrosis |
J:324289
|
|
skeletal muscle fibrosis |
J:324289
|
|
slow postnatal weight gain |
J:324289
|
Dlk1tm1.1Jvs/Dlk1+
Myf5tm3(cre)Sor/Myf5+
involves: 129P2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N
|
abnormal cell differentiation |
J:167124
|
|
decreased body weight |
J:167124
|
|
decreased brown adipose tissue mass |
J:167124
|
|
decreased cell proliferation |
J:167124
|
|
decreased skeletal muscle fiber number |
J:167124
|
|
impaired skeletal muscle regeneration |
J:167124
|
|
increased inflammatory response |
J:167124
|
|
increased skeletal muscle fiber diameter |
J:167124
|
|
increased skeletal muscle fiber size |
J:167124
|
|
maternal imprinting |
J:167124
|
|
skeletal muscle fibrosis |
J:167124
|
Dmdmdx-4Cv/Dmdmdx-4Cv
Myf5tm2Tajb/Myf5tm2Tajb
involves: 129S2/SvPas * C3H/HeHa * C57BL * M. m. castaneus * M. m. musculus
|
increased skeletal muscle fiber diameter |
J:128921
|
|
skeletal muscle fiber necrosis |
J:128921
|
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara
Myf5tm3(cre)Sor/Myf5+
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6
|
decreased brown fat cell size |
J:207678
|
|
decreased brown fat lipid droplet number |
J:207678
|
|
decreased interscapular fat pad weight |
J:207678
|
Elmo1tm1.2Ravi/Elmo1tm1.2Ravi
Elmo2tm1c(EUCOMM)Hmgu/Elmo2tm1c(EUCOMM)Hmgu
Myf5tm3(cre)Sor/Myf5+
involves: 129P2/OlaHsd * C57BL/6N
|
abnormal muscle development |
J:331473
|
|
lethality during fetal growth through weaning, complete penetrance |
J:331473
|
Elmo2tm1c(EUCOMM)Hmgu/Elmo2tm1c(EUCOMM)Hmgu
Myf5tm3(cre)Sor/Myf5+
involves: 129S4/SvJaeSor * C57BL/6N
|
preweaning lethality, incomplete penetrance |
J:331473
|
Erbb2tm1Haus/Erbb2tm1Klee
Gfra1tm3Jmi/Gfra1+
Myf5tm3(cre)Sor/Myf5+
involves: 129S4/SvJae * 129S4/SvJaeSor * 129X1/SvJ
|
abnormal cholinergic neuron morphology |
J:160727
|
|
decreased motor neuron number |
J:160727
|
Erbb2tm1Haus/Erbb2tm1Klee
Myf5tm3(cre)Sor/Myf5+
involves: 129S4/SvJae * C57BL/6
|
abnormal excitatory postsynaptic potential |
J:147957
|
|
abnormal gait |
J:147957
|
|
abnormal muscle spindle morphology |
J:147957
|
|
abnormal posture |
J:147957
|
|
abnormal sensory neuron innervation pattern |
J:147957
|
|
ataxia |
J:147957
|
|
decreased muscle spindle number |
J:147957
|
Fktntm1Kcam/Fktntm1Kcam
Myf5tm3(cre)Sor/Myf5+
involves: 129S/SvEv * 129S4/SvJaeSor
|
decreased body weight |
J:187144
|
|
decreased grip strength |
J:187144
|
|
dystrophic muscle |
J:187144
|
|
increased circulating creatine kinase level |
J:187144
|
|
premature death |
J:187144
|
Fktntm3.1Ttd/Fktntm3.1Ttd
Myf5tm3(cre)Sor/Myf5+
involves: 129S4/SvJaeSor * C57BL/6
|
abnormal muscle precursor cell morphology |
J:198535
|
|
abnormal muscle precursor cell physiology |
J:198535
|
|
centrally nucleated skeletal muscle fibers |
J:198535
|
|
decreased body weight |
J:198535
|
|
decreased satellite cell number |
J:198535
|
|
decreased skeletal muscle weight |
J:198535
|
|
impaired skeletal muscle regeneration |
J:198535
|
|
increased circulating creatine kinase level |
J:198535
|
|
increased collagen deposition in the muscles |
J:198535
|
|
increased variability of skeletal muscle fiber size |
J:198535
|
|
postnatal growth retardation |
J:198535
|
|
premature death |
J:198535
|
|
skeletal muscle atrophy |
J:198535
|
|
skeletal muscle fibrosis |
J:198535
|
|
skeletal muscle necrosis |
J:198535
|
Gdnftm1.1Neas/Gdnftm1.1Neas
Myf5tm3(cre)Sor/Myf5+
involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6 * SJL
|
abnormal cholinergic neuron morphology |
J:160727
|
|
decreased motor neuron number |
J:160727
|
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sor+
Myf5tm3(cre)Sor/Myf5+
involves: 129P2/OlaHsd * 129S4/SvJaeSor
|
abnormal levator veli palatini muscle morphology |
J:310908
|
|
abnormal palatopharyngeus muscle morphology |
J:310908
|
|
abnormal soft palate morphology |
J:310908
|
|
abnormal soft palate muscle morphology |
J:310908
|
|
abnormal superior pharyngeal constrictor muscle morphology |
J:310908
|
|
abnormal tensor veli palatini muscle morphology |
J:310908
|
|
decreased palatal shelf size |
J:310908
|
|
lethality throughout fetal growth and development, complete penetrance |
J:310908
|
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
Myf5tm1(cre)Mrc/Myf5+
involves: 129S1/Sv * 129X1/SvJ
|
abnormal rib morphology |
J:133338
|
|
asymmetric sternocostal joints |
J:133338
|
|
normal
mortality/aging |
J:133338
|
|
rib fusion |
J:133338
|
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
Myf5tm1.1(cre)Mrc/Myf5+
involves: 129S1/Sv * 129X1/SvJ
|
abnormal rib morphology |
J:133338
|
|
normal
muscle phenotype |
J:133338
|
|
neonatal lethality, complete penetrance |
J:133338
|
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sortm1(DTA)Mrc
Myf5tm1(cre)Mrc/Myf5tm1(cre)Mrc
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
decreased body size |
J:120967
|
|
weakness |
J:120967
|
Gt(ROSA)26Sortm2(SS18)Mrc/Gt(ROSA)26Sortm2(SS18)Mrc
Myf5tm1(cre)Mrc/Myf5tm1(cre)Mrc
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
decreased body size |
J:120967
|
|
increased sarcoma incidence |
J:120967
|
|
increased tumor incidence |
J:120967
|
|
postnatal lethality, incomplete penetrance |
J:120967
|
Gt(ROSA)26Sortm3(SS18/EGFP)Mrc/Gt(ROSA)26Sortm3(SS18/EGFP)Mrc
Myf5tm1(cre)Mrc/Myf5tm1(cre)Mrc
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal muscle development |
J:120967
|
|
decreased body size |
J:120967
|
|
increased sarcoma incidence |
J:120967
|
|
increased tumor incidence |
J:120967
|
|
postnatal lethality, incomplete penetrance |
J:120967
|
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+
Myf5tm1(cre)Mrc/Myf5+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
decreased body size |
J:194308
|
|
myopathy |
J:194308
|
|
premature death |
J:194308
|
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Myf5tm3(cre)Sor/Myf5+
involves: 129S4/SvJaeSor * C57BL/6J
|
abnormal brown fat cell differentiation |
J:207891
|
|
abnormal muscle morphology |
J:207891
|
|
decreased brown adipose tissue amount |
J:207891
|
|
decreased muscle weight |
J:207891
|
|
neonatal lethality, complete penetrance |
J:207891
|
|
respiratory failure |
J:207891
|
Lbx1tm1.1Khan/Lbx1tm1.1Khan
Myf5tm3(cre)Sor/Myf5+
involves: 129S4/SvJaeSor * C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj
|
abnormal muscle precursor cell migration |
J:178868
|
|
abnormal skeletal muscle morphology |
J:178868
|
|
decreased body size |
J:178868
|
Lgals1tm1Rob/Lgals1tm1Rob
Myf5tm2Pas/Myf5+
involves: 129S/SvEv * 129S2/SvPas
|
abnormal skeletal muscle fiber morphology |
J:119480
|
|
decreased skeletal muscle fiber diameter |
J:119480
|
|
delayed muscle development |
J:119480
|
|
delayed skeletal muscle regeneration |
J:119480
|
Lin28atm1Gqda/Lin28atm1Gqda
Myf5tm1(cre)Mrc/Myf5+
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
|
normal
growth/size/body region phenotype |
J:199720
|
Lin28atm1Gqda/Lin28atm1Gqda
Myf5tm3(cre)Sor/Myf5+
involves: 129S4/SvJae * C57BL/6 * CD-1
|
impaired glucose tolerance |
J:177113
|
|
insulin resistance |
J:177113
|
Lin28btm1Gqda/Lin28btm1Gqda
Myf5tm1(cre)Mrc/Myf5+
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
|
decreased body size |
J:199720
|
|
impaired glucose tolerance |
J:199720
|
|
insulin resistance |
J:199720
|
|
normal
muscle phenotype |
J:199720
|
Lin28btm1Gqda/Lin28btm1Gqda
Myf5tm1(cre)Mrc/Myf5+
Tsc1tm1Djk/Tsc1+
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6
|
normal
growth/size/body region phenotype |
J:199720
|
Mecomtm1Miku/Mecomtm1Miku
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Myf5tm1(cre)Mrc/Myf5+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JCrlj
|
abnormal interscapular fat pad morphology |
J:213153
|
|
increased brown fat cell lipid droplet size |
J:213153
|
Myf5tm1(cre)Mrc/Myf5+
Myod1tm1Jae/Myod1tm1Jae
Pax7tm1.1Thbr/Pax7tm1.1Thbr
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ
|
decreased satellite cell number |
J:202693
|
Myf5tm1(Pdgfa)Sor/Myf5tm1(Pdgfa)Sor
involves: 129S4/SvJae * C57BL/6J
|
abnormal rib morphology |
J:65301
|
|
abnormal thoracic cage morphology |
J:65301
|
|
fusion of vertebral arches |
J:65301
|
|
increased rib number |
J:65301
|
|
neonatal lethality, complete penetrance |
J:65301
|
Myf5tm1Jae/Myf5+
Myf6tm1Wb/Myf6+
involves: 129S1/Sv * 129S4/SvJae
|
abnormal myotome development |
J:42453
|
|
abnormal rib morphology |
J:42453
|
|
abnormal sternebra morphology |
J:42453
|
|
abnormal sternocostal joint morphology |
J:42453
|
|
perinatal lethality, complete penetrance |
J:42453
|
|
respiratory distress |
J:42453
|
|
rib bifurcation |
J:42453
|
|
rib fusion |
J:42453
|
|
short ribs |
J:42453
|
Myf5tm1Jae/Myf5+
Myf6tm1Eno/Myf6+
involves: 129S4/SvJae * 129S7/SvEvBrd
|
abnormal myotome development |
J:42453
|
|
abnormal rib morphology |
J:42453
|
|
abnormal sternocostal joint morphology |
J:42453
|
|
perinatal lethality, incomplete penetrance |
J:42453
|
Myf5tm1Jae/Myf5+
Myf6tm1Thbr/Myf6+
involves: 129S4/SvJae
|
perinatal lethality, complete penetrance |
J:31636
|
|
short ribs |
J:31636
|
Myf5tm1Jae/Myf5tm1Jae
Myod1tm1.1Glh/Myod1+
involves: 129/Sv * 129S4/SvJae * C57BL/6J
|
abnormal muscle development |
J:87370
|
Myf5tm1Jae/Myf5tm1Jae
Myod1tm1.1Glh/Myod1tm1.1Glh
involves: 129/Sv * 129S4/SvJae * C57BL/6J
|
abnormal muscle development |
J:87370
|
Myf5tm1Pas/Myf5+
Myod1tm1Jae/Myod1tm1Jae
involves: 129 * C57BL/6 * DBA/2
|
postnatal lethality |
J:92799
|
Myf5tm1Pas/Myf5tm1Pas
Myod1tm1Jae/Myod1+
involves: 129 * C57BL/6 * DBA/2
|
postnatal lethality |
J:92799
|
Myf5tm1Pas/Myf5tm1Pas
Myod1tm1Jae/Myod1tm1Jae
involves: 129 * C57BL/6 * DBA/2
|
abnormal myogenesis |
J:92799
|
|
absent skeletal muscle |
J:92799
|
|
postnatal lethality, complete penetrance |
J:92799
|
Myf5tm1Tajb/Myf5tm1Tajb
Myod1tm1Jae/Myod1tm1Jae
involves: 129/Sv * C57BL/6 * DBA/2
|
abnormal myogenesis |
J:92799
|
|
absent skeletal muscle |
J:92799
|
|
postnatal lethality, complete penetrance |
J:92799
|
Myf5tm1Tajb/Myf5tm1Tajb
Pax7tm1.1Tajb/Pax7tm1.1Tajb
involves: 129S2/SvPas
|
abnormal extraocular muscle morphology |
J:150130
|
|
normal
muscle phenotype |
J:150130
|
Myf5tm2(Fgf6)Thbr/Myf5tm2(Fgf6)Thbr
Not Specified
|
normal
skeleton phenotype |
J:63517
|
Myf5tm2(Myog)Jae/Myf5tm2(Myog)Jae
involves: 129S4/SvJae
|
no abnormal phenotype detected |
J:31611
|
Myf5tm2(Myog)Jae/Myf5tm2(Myog)Jae
involves: 129S4/SvJae * C57BL/6J
|
abnormal myotome development |
J:65301
|
|
normal
skeleton phenotype |
J:65301
|
Myf5tm2(Pdgfa)Sor/Myf5tm2(Pdgfa)Sor
involves: 129S4/SvJae * C57BL/6J
|
abnormal cervical vertebrae morphology |
J:65301
|
|
abnormal myotome development |
J:65301
|
|
abnormal rib development |
J:65301
|
|
abnormal rib morphology |
J:65301
|
|
abnormal thoracic cage morphology |
J:65301
|
|
cervical vertebral fusion |
J:65301
|
|
increased bone ossification |
J:65301
|
|
increased rib number |
J:65301
|
|
neonatal lethality, complete penetrance |
J:65301
|
Myf5tm2Tajb/Myf5+
Tbx1tm1Pa/Tbx1tm1Pa
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ
|
abnormal pharyngeal muscle morphology |
J:150130
|
Myf5tm2Tajb/Myf5tm2Tajb
Myf6tm1Tajb/Myf6+
involves: 129S2/SvPas * BALB/c * C57BL/6
|
abnormal muscle development |
J:92799
|
Myf5tm2Tajb/Myf5tm2Tajb
Myf6tm1Tajb/Myf6tm1Tajb
involves: 129S2/SvPas
|
abnormal extraocular muscle morphology |
J:150130
|
|
abnormal eye muscle development |
J:150130
|
Myf5tm2Tajb/Myf5tm2Tajb
Myod1tm1Jae/Myod1tm1Jae
involves: 129/Sv * C57BL/6 * DBA/2
|
abnormal myogenesis |
J:92799
|
|
absent skeletal muscle |
J:92799
|
|
postnatal lethality, complete penetrance |
J:92799
|
Myf5tm2Tajb/Myf5tm2Tajb
Tbx1tm1Pa/Tbx1tm1Pa
involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ
|
abnormal pharyngeal muscle morphology |
J:150130
|
Myf5tm3(cre)Sor/Myf5+
Ntf3tm2Jae/Ntf3tm2Jae
involves: 129S1/Sv * C57BL/6
|
abnormal gait |
J:147957
|
|
abnormal nervous system electrophysiology |
J:147957
|
|
abnormal posture |
J:147957
|
|
ataxia |
J:147957
|
Myf5tm3(cre)Sor/Myf5+
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Alb1-cre)1Dlr/0
involves: 129S4/SvJaeSor * 129S6/SvEvTac * FVB/N
|
decreased body length |
J:119237
|
|
decreased body weight |
J:119237
|
|
decreased circulating insulin-like growth factor I level |
J:119237
|
|
decreased lean body mass |
J:119237
|
|
increased total body fat amount |
J:119237
|
Myf5tm3(cre)Sor/Myf5+
Stat5btm1Mam/Stat5btm1Mam
involves: 129S4/SvJaeSor * 129S6/SvEvTac
|
decreased body length |
J:119237
|
|
decreased body weight |
J:119237
|
|
decreased circulating insulin-like growth factor I level |
J:119237
|
|
decreased lean body mass |
J:119237
|
|
impaired glucose tolerance |
J:119237
|
|
increased circulating triglyceride level |
J:119237
|
|
increased total body fat amount |
J:119237
|
Myf5tm3(cre)Sor/Myf5+
Stat5btm1Mam/Stat5btm1Mam
Tg(Alb1-cre)1Dlr/0
involves: 129S4/SvJaeSor * 129S6/SvEvTac * FVB/N
|
decreased body length |
J:119237
|
|
decreased body weight |
J:119237
|
|
decreased circulating insulin-like growth factor I level |
J:119237
|
|
decreased lean body mass |
J:119237
|
|
increased total body fat amount |
J:119237
|
Myf5tm3(cre)Sor/Myf5+
Tg(CAG-Nog)1Ych/0
involves: 129S4/SvJaeSor
|
abnormal levator veli palatini muscle morphology |
J:310908
|
|
abnormal palatopharyngeus muscle morphology |
J:310908
|
|
abnormal soft palate muscle morphology |
J:310908
|
|
abnormal superior pharyngeal constrictor muscle morphology |
J:310908
|
|
abnormal tensor veli palatini muscle morphology |
J:310908
|
|
cleft soft palate |
J:310908
|
Myf5tm3(cre)Sor/Myf5+
Tg(ACTB-Edn1)721Clou/0
involves: 129S4/SvJaeSor * C57BL/6
|
abnormal costal cartilage morphology |
J:221133
|
Myf5tm3(cre)Sor/Myf5+
Tg(ACTB-Edn1)1398Clou/0
involves: 129S4/SvJaeSor * C57BL/6
|
abnormal costal cartilage morphology |
J:221133
|
|
rib fusion |
J:221133
|
Myf5tm3(cre)Sor/Myf5+
Tg(ACTB-Edn1)1408Clou/0
involves: 129S4/SvJaeSor * C57BL/6
|
abnormal costal cartilage morphology |
J:221133
|
|
rib fusion |
J:221133
|
Myf5tm3(cre)Sor/Myf5+
Tg(ACTB-Edn1)1416Clou/0
involves: 129S4/SvJaeSor * C57BL/6
|
abnormal costal cartilage morphology |
J:221133
|
|
rib fusion |
J:221133
|
|
upper jaw to lower jaw transformation |
J:221133
|
Myf5tm3(cre)Sor/Myf5+
Sik1tm1.1Berd/Sik1tm1.1Berd
involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * SJL
|
abnormal gluconeogenesis |
J:236223
|
|
abnormal glucose homeostasis |
J:236223
|
|
decreased circulating insulin level |
J:236223
|
|
improved glucose tolerance |
J:236223
|
|
increased insulin sensitivity |
J:236223
|
|
increased muscle cell glucose uptake |
J:236223
|
|
normal
muscle phenotype |
J:236223
|
Myf5tm3(cre)Sor/Myf5+
Spin1tm1.1Rosc/Spin1tm1.1Rosc
involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NTac
|
abnormal diaphragm morphology |
J:302851
|
|
abnormal forelimb morphology |
J:302851
|
|
abnormal M line morphology |
J:302851
|
|
abnormal myogenesis |
J:302851
|
|
abnormal neuromuscular synapse morphology |
J:302851
|
|
abnormal posture |
J:302851
|
|
abnormal skeletal muscle fiber morphology |
J:302851
|
|
abnormal skeletal muscle fiber type ratio |
J:302851
|
|
abnormal skeletal muscle morphology |
J:302851
|
|
abnormal soleus morphology |
J:302851
|
|
abnormal tibialis anterior morphology |
J:302851
|
|
absent gastric milk in neonates |
J:302851
|
|
cachexia |
J:302851
|
|
decreased body weight |
J:302851
|
|
decreased skeletal muscle fiber number |
J:302851
|
|
decreased skeletal muscle mass |
J:302851
|
|
increased skeletal muscle fiber size |
J:302851
|
|
neonatal lethality, incomplete penetrance |
J:302851
|
|
scoliosis |
J:302851
|
|
skeletal muscle degeneration |
J:302851
|
|
skeletal muscle fiber degeneration |
J:302851
|
|
skeletal muscle fiber necrosis |
J:302851
|
|
skeletal muscle fibrosis |
J:302851
|
Myf5tm3(cre)Sor/Myf5tm3(cre)Sor
Myod1tm1Jae/Myod1tm1Jae
involves: 129S4/SvJae * C57BL/6J
|
abnormal myogenesis |
J:65301
|
|
abnormal myotube morphology |
J:65301
|
Myf5tm4(Myod1)Sor/Myf5tm4(Myod1)Sor
involves: 129S4/SvJae * C57BL/6J
|
normal
muscle phenotype |
J:65301
|
|
normal
skeleton phenotype |
J:65301
|
Pax7tm1.1Thbr/Pax7tm1.1Thbr
Myf5tm1(cre)Mrc/Myf5+
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ
|
decreased satellite cell number |
J:202693
|
Pax7tm1.1Thbr/Pax7tm1.1Thbr
Myf5tm3(cre)Sor/Myf5+
involves: 129S4/SvJaeSor
|
decreased body size |
J:202693
|
|
decreased satellite cell number |
J:202693
|
|
decreased skeletal muscle fiber diameter |
J:202693
|
|
decreased skeletal muscle fiber number |
J:202693
|
|
impaired skeletal muscle regeneration |
J:202693
|
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp
Myf5tm1(cre)Mrc/Myf5+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal brown adipose tissue morphology |
J:213153
|
|
abnormal brown adipose tissue thermogenesis |
J:213153
|
|
abnormal cellular respiration |
J:213153
|
|
abnormal interscapular fat pad morphology |
J:213153
|
|
abnormal oxygen consumption |
J:213153
|
|
decreased body fat mass |
J:213153
|
|
decreased body length |
J:213153
|
|
decreased body weight |
J:213153
|
|
decreased brown fat lipid droplet number |
J:213153
|
|
decreased fat cell mitochondrial DNA content |
J:213153
|
|
decreased lean body mass |
J:213153
|
|
decreased mitochondrial number |
J:213153
|
|
impaired adaptive thermogenesis |
J:213153
|
|
improved glucose tolerance |
J:213153
|
|
increased brown fat cell lipid droplet size |
J:213153
|
|
increased interscapular fat pad weight |
J:213153
|
|
whitened brown adipose tissue morphology |
J:213153
|
Prox1tm2Gco/Prox1tm2Gco
Myf5tm3(cre)Sor/Myf5+
involves: 129S1/Sv * 129S4/SvJae * C57BL/6J
|
abnormal skeletal muscle morphology |
J:212185
|
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Myf5tm3(cre)Sor/Myf5+
involves: 129S4/SvJaeSor * 129S6/SvEvTac
|
decreased body length |
J:119237
|
|
decreased body weight |
J:119237
|
|
decreased circulating insulin-like growth factor I level |
J:119237
|
|
decreased lean body mass |
J:119237
|
|
impaired glucose tolerance |
J:119237
|
|
increased circulating triglyceride level |
J:119237
|
|
increased total body fat amount |
J:119237
|
Zfp422em1Mode/Zfp422em1Mode
Myf5tm3(cre)Sor/Myf5+
involves: 129S4/SvJaeSor * C57BL/6J
|
abnormal myoblast differentiation |
J:297035
|
|
abnormal skeletal muscle fiber morphology |
J:297035
|
|
decreased fetal weight |
J:297035
|
|
decreased skeletal muscle fiber size |
J:297035
|
Excel File
Analysis Tools